GLP1R and type 2 diabetes mellitus: Additionally, another study examined the impact of hGIP injection on PP secretion in overweight/obese individuals with type 2 diabetes mellitus who were undergoing treatment with metformin and a long-acting GLP-1 receptor agonist [37].